CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Conference Call27-08-2020
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Group Analyst Meeting21-08-2020
Earnings Call Transcript - Q1FY21 for Caplin Point Labs
Conference Call with Caplin Point Laboratories Management and Analysts on Q1FY21 Performance and Outlook. Listen to the full earnings transcript.12-08-2020
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Investor Presentation
CORRIGENDUM TO INVESTORS PRESENTATION FOR JUNE, 202011-08-2020
CAPLIN POINT LABORATORIES LTD. - 524742 - Outcome of Board Meeting (AGM on Sept 28, 2020)
Caplin Point Laboratories Ltd has informed BSE about Outcome of Board Meeting held on August 10, 2020.10-08-2020
CAPLIN POINT LABORATORIES LTD. - 524742 - Un-Audited Financial Results (Consolidated And Standalone) For The Quarter Ended June 30, 2020
Un-audited Financial Results (Consolidated and Standalone) for the quarter ended June 30, 202010-08-2020
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
CONFERENCE CALL ON TUESDAY, AUGUST 11, 202003-08-2020
CAPLIN POINT LABORATORIES LTD. - 524742 - Board Meeting Intimation for Considering Un-Audited Financial Results For Quarter Ended June 30, 2020
CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2020 ,inter alia, to consider and approve Un-audited Financial Results for quarter ended June 30, 202003-08-2020